Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
Joura, Elmar A, MD, Leodolter, Sepp, Prof, Hernandez-Avila, Mauricio, Prof, Wheeler, Cosette M, Prof, Perez, Gonzalo, MD, Koutsky, Laura A, Prof, Garland, Suzanne M, Prof, Harper, Diane M, Prof, Tang, Grace WK, Prof, Ferris, Daron G, Prof, Steben, Marc, Prof, Jones, Ronald W, MD, Bryan, Janine, PhD, Taddeo, Frank J, PhD, Bautista, Oliver M, PhD, Esser, Mark T, PhD, Sings, Heather L, PhD, Nelson, Micki, BS, Boslego, John W, MD, Sattler, Carlos, MD, Barr, Eliav, MD, Paavonen, Jorma, Prof
Published in The Lancet (British edition) (19.05.2007)
Published in The Lancet (British edition) (19.05.2007)
Get full text
Journal Article